Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Impact of antibiotic administrative restrictions on trends in antibiotic resistance.

Marshall DA, McGeer A, Gough J, Grootendorst P, Buitendyk M, Simonyi S, Green K, Jaszewski B, MacLeod SM, Low DE.

Can J Public Health. 2006 Mar-Apr;97(2):126-31.

PMID:
16620000
2.

Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis.

Marshall D, Gough J, Grootendorst P, Buitendyk M, Jaszewski B, Simonyi S, Jivraj F, Macleod S.

J Health Serv Res Policy. 2006 Jan;11(1):13-20.

PMID:
16378528
3.

[Dynamics of Streptococcos pneumoniae antibiotic resistance extension in Moscow in 1998-2003].

Grudinina SA, Sidorenko SV, Fedorchuk VV, Katosova LK, Fatova NA, Eremina LV, Furletova NM, Iutanova NS.

Antibiot Khimioter. 2004;49(4):25-34. Russian.

PMID:
15460020
5.

Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population.

Woolfson A, Huebner R, Wasas A, Chola S, Godfrey-Faussett P, Klugman K.

Bull World Health Organ. 1997;75(5):453-62.

7.

[Antibiotic sensitivity of Streptococcus pneumoniae in Tunisia: results of a multicenter study (1998-1999)].

Mahjoubi-Rhimi F, Kechrid A, Boutiba I, Mezghani S, Kamoun A, Smaoui H, Thabet L, Ben Redjeb S, Hammami A.

Tunis Med. 2003 Mar;81(3):167-71. French.

PMID:
12793066
8.

Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.

Jones RN, Sader HS, Stilwell MG, Fritsche TR.

Diagn Microbiol Infect Dis. 2007 May;58(1):1-7. Epub 2007 Apr 3.

PMID:
17408904
9.

[In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].

Uncu H, Colakoğlu S, Turunç T, Demiroğlu YZ, Arslan H.

Mikrobiyol Bul. 2007 Jul;41(3):441-6. Turkish.

PMID:
17933256
10.

Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease.

Soeters HM, von Gottberg A, Cohen C, Quan V, Klugman KP.

Antimicrob Agents Chemother. 2012 Mar;56(3):1602-5. doi: 10.1128/AAC.05813-11. Epub 2012 Jan 9.

11.

Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada.

Carrie AG, Metge CJ, Collins DM, Harding GK, Zhanel GG.

Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):863-70.

PMID:
15386718
12.

Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae.

Widdowson CA, Klugman KP.

Semin Respir Infect. 1999 Sep;14(3):255-68. Review.

PMID:
10501313
13.

Eleven-year surveillance of antibiotic resistance in Streptococcus pneumoniae in Casablanca (Morocco).

Benbachir M, Elmdaghri N, Belabbes H, Haddioui G, Benzaid H, Zaki B.

Microb Drug Resist. 2012 Apr;18(2):157-60. doi: 10.1089/mdr.2011.0130. Epub 2012 Jan 4.

PMID:
22217142
14.

[Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].

Sun HL, Yang QW, Xu YC, Wang H, Xie XL, Chen MJ, Zhang XZ, Liu Y, Ye HF, Sun ZY, Duan Q, Ni YX, Yu YS, Zhao WS, He L, Wang J, Ji P, Liu PP, Zhang LX.

Zhonghua Yi Xue Za Zhi. 2009 Nov 17;89(42):2983-7. Chinese.

PMID:
20137709
16.

Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.

Zafar A, Hasan R, Nizamuddin S, Mahmood N, Mukhtar S, Ali F, Morrissey I, Barker K, Torumkuney D.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i103-9. doi: 10.1093/jac/dkw076.

17.

Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.

Rosón B, Carratalà J, Tubau F, Dorca J, Liñares J, Pallares R, Manresa F, Gudiol F.

Microb Drug Resist. 2001 Spring;7(1):85-96.

PMID:
11310807
18.

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, Whitney CG.

Arch Intern Med. 2000 May 22;160(10):1399-408.

PMID:
10826451
19.

Supplemental Content

Support Center